Cancer induction following single and multiple exposures to a constant amount of vinyl chloride monomer. by Hehir, R M et al.
Environmental Health Perspectives
Vol. 41, pp. 63-72, 1981
Cancer Induction Following Single and
Multiple Exposures to a Constant
Amount of Vinyl Chloride Monomer
by Robert M. Hehir,* Bernard P. McNamara,t**
Joseph McLaughlin, Jr.,* Donald A. Willigan,*
George Bierbower* and Jerry F. Hardistyt
Vinyl chloride monomer (VCM), already identified as a human animal carcinogen, was
selected as a model agent to explore an area of concern for single and intermittent low level
exposure. In traditional cancer bioassay, animals are repeatedly exposed over their lifespan to a
dose of suspected chemical.
In the current studies rats and mice were exposed in an inhalation chamber to single one-hour
doses of VCM ranging from 50 to 50,000 ppm.
A second group was given 10 one-hour exposures to 500 ppm or 100 one-hour exposures to 50
ppm of the same chemical. All animals were then observed for the remainder of their lives,
generally 18-24 months. Moribund animals were euthanized, and survivors were sacrificed on
schedule and their tissues examined for pathological changes. Specifically, the oncogenic study
demonstrated dose related effects for single one-hour exposure ofVCM at high levels, i.e., 5,000
and 50,000 ppm. These concentrations increased the incidence of pulmonary adenomas and
carcinomas in mice.
Repeated exposure ofA/J mice to the same chemical at 500 ppm x 10 one-hour exposures also
increased the incidence of pulmonary adenomas and carcinomas which are considered highly
significant (p = 0.001) when compared to match controls. At the lower dose of 50 ppm x 100
one-hour exposure, no significant increase in tumors was observed. Rats exposed to identical
concentrations ofVCM failed to elicit a tumorigenic response.
Introduction
In the last decade there have been concerted
efforts by industry and the Federal government to
identify carcinogenic substances in the workplace.
However, carcinogens are not limited to occupa-
tional exposures. Many ofthese same chemicals are
also used in the formulation ofhousehold products.
Therefore, consumers in all walks of life may be
exposed to suspect chemicals in their homes without
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theirknowledge. This type ofconsumerexposure is
usually brief and at very low levels. The suspect
chemical may be modified in the process of manu-
facturing the consumer product, i.e., as in the case
of polymerization of vinyl chloride (VC) to poly(vi-
nyl chloride) (PVC), or trace quantities of the
unreacted monomer may be present in the product
which may be leached out under normal conditions
ofuse. There are other situations wherein a chemi-
callike VC is used because itis chemicallyinert, for
example as a propellant, and as an unreacted
gaseous chemical it could become a potential health
problem.
While regulatory bodies try to establish safe
exposure levels and industry attempts to control
exposures in the production facilities, no such
control measures would be ofpractical value in the
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ed with making value judgements about potential
risks of consumer exposure is that traditional
cancerbioassays involve daily exposures to the test
chemical over the animal's lifetime. There were no
comparable studies on short-term exposure to a
carcinogen like VC followed by a lifetime monitor-
ing for toxicological symptoms with complete
histopathological examination at death. Therefore,
our approach was to explore what happens to
laboratory animals following brief or intermittent
exposure to a known carcinogen like VC. Vinyl
chloride appeared to be the ideal chemical to use in
these experiments because ofits widespread use in
industrial and consumer products. Furthermore,
the relationship for inducing unique pathological
lesions, i.e., angiosarcoma of the liver for high
exposure levels in animal and man was already
established by Viola et al. (1) Maltoni (2) and
Creech et al. (3).
Quite apart from the need to establish a bench
mark for acute short-term intermittent exposures
to a carcinogen, such as vinyl chloride, was the
question of"threshold effects" or"safety factor" for
low level exposures. In setting up our experiments
we were mindful of the many factors that could
have an impact on the study design. Some of the
more important factors are that (1) the substance
may not reach a susceptible cell; (2) the substance
may make noncarcinogenic biochemical combina-
tion with the cell; (3) the "initiated" lesion may not
receive adequate "promotion"; (4) host factors may
be unfavorable to carcinogenesis; (5) biochemical
repair ofthe DNAlesion may occur; (6) morpholog-
ical regression of tumorigenic proliferation may
occur; (7) carcinogenic cells may be destroyed by
the body's immune system. These items need to be
addressed in any conventional cancer bioassay but
areevenmorecriticalinsearchingfornoncarcinogenic
exposure levels.
Experimental Conditions
Two strains of rats, Fischer 344 (Charles River
Laboratory, Wilmington, Mass.) and Sprague-
Dawley/Wistar (Chemical Systems Lab, Edgewood,
Md.), and two strains of mice, A/J (Jackson Lab,
Bar Harbor, Maine) and ICR (Charles River Labo-
ratory) were treated in single or multiple intermit-
tent inhalation exposures to VC. The chambers
were Rochester type, stainless steel, 1000 liter,
constructed to provide laminar air flow and insure
uniform exposures to VC to test animals.
Chamber concentrations were established by
proportioning the amounts of VC being dispersed
with the air flow through the chamber. Airflow
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through the chamber was created by a blower
motorlocated inthe flow pipe on the exhaust side of
the chamber. A negative pressure was maintained
in the chamber at all times when operational and
the exhaust gas completely filtered (M6AI gas-
particulate filter) before discharge to the environ-
ment. The concentration of gas in the inhalation
chamber was monitored by using a Hewlett-
Packard 5830A gas chromatograph with a dual
flame ionization detector.
Exposure Procedures for VC Lifetime
Cancer Studies
Male and female rats and Fischer 344 and ICR
mice were totally exposed for 1 hr to 50, 500, 5000
and 50,000 ppm VC. Fischer rats and A/J mice
equally divided by sex received ten 1 hr exposures
to 500 ppm VC (1 hr/day, 5 days/wk for 2 weeks) or
100 1-hr exposures to 50 ppm (1 hr/day, 5 days/wk
for 20 weeks). Male and female parents (Sprague-
Dawley/Wistar)rats(obtainedfromVeterinaryMed-
ical Division, Edgewood Arsenal, Md.) from the
reproduction study were also maintained and ob-
served for 24 months post exposure to 50 to 500
ppmVC 1 hr per day, 5 days perweek for 10 weeks
(49 exposures).
Following exposure, all animals were air washed
until the chamber concentration was less than 1
ppm VC. Animals ofthe same sex were segregated
in stainless steel cages with a maximum number of
5rats in eachcompartment and placed inthe animal
holdingarea. Micewere similarlytreated, but smaller
cages were used and the number of mice per com-
partment was limited to two. The animals were
observed twicedailyforgeneralhealth, sores, mass-
es, alertness, activity or mortality. All animals
were weighed weekly for the first 8 weeks post
exposure and monthly thereafter. The exposure
schedules forthe studies described above are shown
in Tables 1-3. No blood chemistries or hematology
studies were performed.
Pathology
Gross andLightMicroscopy. A complete gross
and microscropic examination was performed on
most control and exposed animals which died or
were sacrificed. Autolysis precluded such examina-
tion in a few cases.
All rodents were to be serially sacrificed at 8, 16
and 24 months post exposure. However, the life
span of the mice forced some changes in the later
times of sacrifice and termination of mouse experi-
ments. For single exposure the planned 16 and 24
monthsacrifice werereplacedby 18monthsacrifices.
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Exposure date Exposure Age at time of
group size exposure, weeks
Species Sex Dose, ppm AM PM
Fischer 344 rat M 50 3/4/75 90 15
500 3/11/75 90 16
5000 3/18/75 85 17
50000 3/25/75 90 18
F 50 3/4/75 90 15
500 3/11/75 100 16
5000 3/18/75 95 17
50000 3/25/75 88 18
ICR mouse M 50 3/4/75 90 15
500 3/11/75 90 16
5000 3/18/75 90 17
50000 3/25/75 90 18
F 50 3/4/75 90 15
500 3/11/75 90 16
5000 3/18/75 90 17
50000 3/25/75 90 18
Rat M Neg/Cont. 92 15-18
F Neg/Cont. 79 15-18
Mouse M Neg/Cont. 82 15-18
F Neg/Cont. 88 15-18
Table 2. Exposure schedule for animals exposed repeatedly to VC.
Exposure Exposure dates Exposure group size Age, weeks
periods,
Species Sex Dose, ppm days From To Start End Start End
Fischer rat M 50 100 8/27/75 1/26/76 90 86 21 41
A/J mouse
Fischer rat
A/J mouse
F
M
F
M
F
M
F
500 10 7/7/75 7/28/75 90 90 14 16
50 100 8/27/75 1/26/76 90 87 21 41
500 10 7/7/75 7/18/75 90 90 14 16
50 100 7/7/75 7/18/75 90 87 15 35
500 10 8/27/75 1/26/76 90 90 8 10
50 100 7/7/75 7/18/75 90 88 15 35
500 10 8/27/75 1/26/76 90 90 8 10
Neg. 100(c)a - 50 50 21 41
Control 10(c) 50 50 14 16
Neg. 100(c) 50 47 21 41
Control 10(c) 50 50 14 16
Neg. 100(c) 40 39 15 35
Control 10(c) 50 50 8 10
Neg. 100(c) 50 50 15 35
Control 10(c) 50 50 8 10
a(c) denotes control for corresponding dose above.
Table 3. VC multigeneration study, Fo parents.a
Group Compound Doseb Number of males Number of females
I Air Control 25 25
II VC Low dose 25 25
(50 ppm)
III VC High dose 25 25
(500 ppm)
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aSpraue-Daley/Wstar rats.
bExposure to 50 or 500 PPM of VC 1 hr/day, 5 days/week for 10 weeks (49 exposures) before mating.
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by the National Cancer Institute (4) for cancer
bioassays in smallanimals. Formultiple dose studies
in mice the final sacrifice was at 20 months rather
than 24 months. The change was made in consider-
ation of the risk of animal loss through death and
possible cannibalism. Tissues examined were lung,
trachea, heart, liver, stomach, small intestines,
spleen, kidney, bladder, bone marrow (sternum),
adrenals, pancreas, duodenum, brain, eye, zymbal
gland, ear, nose, muscle and bone (femur).
Electron Microscopic Studies. Groups of five
male and five female Fisher (344) rats from each of
the single 1-hr exposure studies (50, 500, 5000 and
50,000 ppm) with equal numbers of their corres-
ponding control groups were sacrificed at 8, 16, 24
months.
Groups offive male and five female Fischer (344)
rats from the multiple 1-hr exposure studies at
50 and 500 ppm VC along with equal numbers of
control animals were sacrificed at 16 and 24months.
Results
Toxicity During Exposure
Rats and mice exposed for 1 hr to concentrations
ofVC ranging from 50 to 50,000 ppm or for repeat-
ed exposures, i.e., 50 ppm or 500 ppm, produced no
remarkable signs of toxicity with the exception of
mice at the 50,000 ppm level. At 50,000 ppm VC
50% ofthe male mice exhibited hyperventilation at
45 minutes together with twitching and possible
ataxia. Female mice became hyperactive after 40
min exposure, and respiratory difficulty and ataxia
was observed in approximately 25% of the female
mice after 55 min. Upon removal from the test
atmosphere, all animals recovered to normal
appearance within 24 hr. After exposure there were
no consistent or dose-related differences between
control and exposed (single ormultiple) mice orrats
in death rate, toxic signs or change in body weight.
Gross Pathology
There was a suggestion of higher frequency of
masses in the lungs and livers ofmice exposed once
or repeatedly to VC at the higher dose levels, i.e.,
500, 5000 or 50,000 ppm.
Histological Examination of ICR
Mice: Single Exposure
Changes ascribable to vinyl chloride were appar-
ent primarily in the lungs with the induction of
pulmonary adenomas and pneumonitis. Pneumonitis
was evident in all animal groups which were ex-
posed to VC at 500 ppm and above.
The development of bronchio-alveolar adenomas
increased with exposure to higher dose levels of
VC. Tables 4 and 5 summarize the significant histo-
logical changes observed in ICR mice at 8 and 18
months following single exposure to graded doses
of VC.
Mice were more susceptible than rats to pneu-
monitis following exposure to VC. The effect how-
ever was not incremental with dose level. The
incidence of pneumonitis, adenoma and carcinoma
in ICR mice following single exposure is presented
in Table 6. No correlation was observed between
the incidence of pneumonitis and adenoma or
pneumonitisandcarcinoma. However, malesseemed
more prone to the induction ofpneumonitis, partic-
ularly at 50,000 ppm, i.e., 34% M vs. 13% F. At
5000 ppm and below, male and females were about
equally sensitive.
There was an increase in bronchio-alveolar ade-
nomas with exposure to higher doses ofVC and the
condition manifests itself more frequently in males,
i.e., at 50,000 ppm: 51% M vs. 18% F. This trend
continued atthe 5000 ppm: 22% M vs. 13% F. Males
and females were equally susceptible at dose level
500 ppm and below. The upper respiratory tract
(nasal turbinates) and trachea revealed no unusual
changes specifically attributable to VC.
Table 4. Histological examination ofICRmice at 8 and 18 monthsfollowing asingle (1-hr) exposure tovinyl chloride monomer.
Histological changes attributable to vinyl chloride
Vinyl chloride concentration, ppm Induction of pulmonary adenomas Progression to carcinoma
50,000a 45/137 (33.3%) 3/137 (2.2%)
5,000a 24/143 (16.8%) 1/143 (0.7%)
500a 18/139 (12.9%) 1/139 (0.7%)
50 14/139 (10.1%) 0/139 (0%)
0 (control) 12/120 (10.0%) 0/120 (0%)
aPneumonitis was evident in all animal groups which were exposed to VCM at doses of 500 ppm or more.
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at 8, 16 and 20 Months Following
Multiple Exposure
500 ppm, 10 days, I hr. Changes ascribable to
VC were apparent in the lung only, primarily the
induction ofpulmonaryadenomas. Bronchio-alveolar
adenomas were induced in the test group with
approximatelyequalfrequencyinmalesandfemales,
i.e., 73.7% M vs. 75.6% F, respectively. The in-
crease in incidence as shown in Table 7 for the test
group over that ofthe controls was substantial, by
a factor of2.2, i.e., controls, 34.4%; 500 ppm; 74.7.
Progression tomalignancy (carcinoma) inthe test
group vs. controls was also highly significant: con-
trols, 3/90 or 3.3%; 500 ppm, 22/166 or 13.3%. In
animals scheduled for evaluation (survivors) pul-
monary adenomas were observed as early as 8
months post exposure in 60% ofmales and females;
at 20 months, 75% of animals were affected.
The incidence of pneumonitis, adenoma and car-
cinoma in A/J mice following multiple exposure to
VC is presented in Table 8. Pneumonitis was ob-
served more frequently in the control animal than
Table 5. Overall summary: incidence ofnonneoplastic changes and histologicallyproven neoplasmswithinthe liverand lungs of
ICR Swiss mice exposed to vinyl chloride in single inhalation exposures.
Incidence of response for various vinyl chloride conens
0 50,000 ppm 5,000 ppm 500 ppm 50 ppm
Tissue/response M (62)a F (77)a M (74)a F (82)a M (76)a F (82)a M (72)a F (75)a M (81)a F (80)a
Liver (number evaluated) 50 75 63 78 68 76 67 72 64 68
Hepatic cell necrosis 2 10 3 5 5 7 4 6 2 3
Hepatic cell vacuolation
(lipidosis) 2 11 4 2 12 3 5 1 4
Hepatic cell hypertrophy 1 2 8 8 4 13 1
Hepatic cell hyperplasia 4 4
Angiectasis 1 4
Sinusoidal reticulosis 5
Hepatic cell adenoma 2 1 1 2
Hepatic cell carcinoma 2 4 1 6 1 9 2
Hemangioma 1
Hemangiosarcoma 1
Lung (number evaluated) 50 70 61 76 65 78 66 73 71 68
Pneumonitis 1 6 21 10 13 17 19 15 4 7
Bronchio-alveolar adenoma 4 8 31 14 14 10 8 10 8 6
Bronchio-alveolar carcinoma 1 2 1 1
aNumbers in parentheses denote animals per group. Total includes animals from scheduled sacrificed (8 and month periods) and
spontaneous deaths.
Table 6. Single inhalation exposure of ICR mice to vinyl chloride monomer.
Lung tissue: incidence of response/number evaluated'
VCoenxcnpure Group Pneumonitis Adenoma Carcinoma
0 (control) Male 1/50 (2%) 4/50 (8%) 0/50 (0%)
Female 6/70 (9%) 8/70 (11%) 0/70 (0%)
Combined (M +F) 7/120 (6%) 12/120 (10%) 0/120 (0%)
50,000 Male 21/61 (34%) 31/61 (51%) 1/61 (2%)
Female 10/76 (13%) 14/76 (18%) 2/76 (3%)
Combined (M +F) 31/137 (23%) 45/137 (33%) 3/137 (2%)
5,000 Male 13/65 (25%) 14/65 (22%) 1/65 (2%)
Female 17/78 (22%) 10/78 (13%) 0/78 (0%)
Combined (M+F) 30/143 (21%) 24/143 (17%) 1/143 (1%)
500 Male 19/66 (29%) 8/66 (12%) 0/66 (0%)
Female 15/73 (21%) 10/73 (14%) 1/73 (1%)
Combined (M+F) 34/139 (24%) 18/139 (13%) 1/139 (1%)
50 Male 4/71 (6%) 8/71 (11%) 0/71 (0%)
Female 7/68 (10%) 6/68 (9%) 0/68 (0%)
Combined (M +F) 11/139 (8%) 14/139 (10%) 0/139 (0%)
"Total includes animals from scheduled sacrifice (8, 16, 20 months period) and spontaneous deaths.
October 1981 67in either test group. No correlation was observed
between the incidence ofpneumonitis and adenoma
or for pneumonitis and carcinoma. These results
are similarto those observed in the single exposure
study.
50ppm, 100days, I hr. Againchanges attribut-
able to VC were apparent in the lung only, primari-
ly pulmonary adenomas. However, the incidence in
the induction ofadenomas and progression to carci-
noma are considered only marginal and not statisti-
cally significant.
Comparatively, the potential for development of
pulmonary adenomas as shown inTable 7was great-
er in A/J mice following multiple exposures at 500
ppm than at 50 ppm, i.e., incidence at 500 ppm,
74.7%; at 50 ppm, 44.1%, despite an equivalent
totaldoseof5000ppmVC. Also, pulnonaryadenomas
were induced earliest (8 months) following multiple
exposures at 500 ppm. It is also ofinterest that the
Table 7. Histological examination ofA/J mice at 8, 16 and 20
months following multiple (1-hr) exposures to vinyl chloride
monomer.
Histological changes attributable to
Number of vinyl chloride monomer
exposures and
concentration Induction of Progression
of VCM pulmonary adenomas to carcinoma
0 (controls) 31/90 (34.4%) 3/90 (3.3%)
10 x 500 ppma 124/166 (74.7%) 22/166 (13.3%)
0 (controls) 29/84 (34.5%) 2/84 (2.4%)
100 x 50 ppmb 65/158 (44.1%) 7/158 (4.4%)
aHighly significant difference in the number of pulmonary
adenomas (p20.001) observed at the 500 ppm x 10 hr exposure
level versus control by Z test.
bNo significant difference for pulmonary adenomas (p < 0.14)
and carcinomas (p 2 0.19) observed at the lower multiple
exposure level.
controlgroups ofA/J miceforbothmultiple inhalation
studies showed a baseline incidence for pulmonary
adenomas which was nearly identical, i.e., at 500
ppm, 34.4%; at 50 ppm, 34.5%.
Table 9 provides an overall summary ofthe inci-
dence of histologically proven neoplasms observed
in both strains ofmice, i.e., ICR and A/J, following
single and multiple exposures to VC. The neoplas-
tic and nonneoplastic changes observed in the liver
and/or lungs of A/J mice following multiple expo-
sures to VC at 50 and 500 ppm are shown in Tables
10 and 11. Although other neoplasms and nonneo-
plastic changes occurred variously in all remaining
organs and tissues, the response appeared either
sporadically orwas shared byalltest groups includ-
ingcontrols. Relationship byincidence and severity
to test exposure was not evident. Furthermore,
morphologic deviations were not unlike those nor-
mally observed in aging A/J mice maintained under
standard laboratory conditions.
Electron Microscopic Results
In general, these studies indicate that exposure
tovinylchlorideincreasedorganelleturnoveraswell
as loss of volume control (bleb formation) and in-
creased lysosomal activity in the liver ofrats. These
alterationsprogressivelydecreasedasrecoveryafter
exposure increased.
Hepatocellular carcinoma was seen in one male
Fischer rat which had received 10 exposures of500
ppm. Lymphosarcoma was noted in one female
Fischerrat which had received a single exposure at
500 ppm. Since these were individual cases and
since no cancers were seen at 50,000 ppm, the
lymphosarcoma and the hepatocellular carcinoma
are not likely related to vinyl chloride exposure.
Table 8. Multiple inhalation exposure of A/J mice to vinyl chloride monomer.
VC Exposure Lung tissue: incidence of response/number evaluateda
Frequency conen, ppm Group Pneumonitis Adenoma Carcinoma
10 x 1 0 Male 0/43 (0%) 15/43 (35%) 0/43 (0%)
Female 2/47 (4%) 16/47 (34%) 3/47 (6%)
Combined (M+F) 2/90 (2%) 31/90 (34%) 3/90 (3%
10 x 1 500 Male 0/76 (0%) 56/76 (74%) 12/76 (16%)
Female 0/90 (0%) 68/90 (76%) 10/90 (11%)
Combined (M+F) 0/166 (0%) 124/166 (75%) 22/166 (13%)
100 x 1 0 Male 5/39 (13%) 11/39 (28%) 2/39 (5%)
Female 3/45 (7%) 18/45 (40%) 0/45 (0%)
Combined (M +F) 8/84 (10%) 29/84 (35%) 2/84 (2%)
100 x 1 50 Male 4/77 (5%) 27/77 (35%) 3/77 (4%)
Female 5/81 (6%) 38/81 (47%) 4/81 (5%)
Combined (M+F) 9/158 (6%) 65/158 (41%) 7/158 (4%)
aTotal includes animals from scheduled sacrifice (8, 16, 20 months period) and spontaneous deaths.
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One hundred and fifty colony rats (Sprague-
Dawley/Wistar) were divided into three groups
with equal numbers of males and females. These
specific-pathogen-free, random bred animals were
obtained from the Animal Resources Branch at
Edgewood Arsenal. The rats were 12 weeks old
when initially exposed to VC. One hundred rats
were exposed as described and the remaining 50
were carried as unexposed controls. The parental
generations ofS-D/Wrats weremaintained24months
post exposure for carcinogenic evaluation.
A complete gross and microscopic pathological
examination of all tissues was performed on each
control and exposed animal. Particular emphasis
was placed on examination ofbrain, lung, and liver
tissues and zymbal gland in the rodent ear. The
livers ofrandomly selected rats were prepared and
examined by electron microscopic techniques.
Neoplastic and nonneoplastic lesions were observed
in approximately equal frequency in control and Fo
parent generation of Sprague-Dawley/Wistar rats
exposed to 50 ppm or 500 ppm ofVC, 1 hr per day,
five days per week for 10 weeks (49 exposures).
The only lesions that occurred in higher frequen-
cy in the exposed animals than in control rats were
eosinophilic cellular alterations presented as foci/ or
areas. The appearance of these foci was related to
the dosage ofVC. The nature ofthese lesions are of
interest but as yet are controversial, so that no
inference can be drawn.
Table 9. Summary ofincidence ofhistologically proven neoplasms observed within tissues ofmice at various intervals following
single or multiple exposures to vinyl chloride monomer.
Number of neoplasms observed (scheduled sacrifice) Total
Exposure number of
Inhalation concentration, 8 16 18 20 neoplasms
exposure ppm months months months months Totals observed
Single (1 hr) 50,000 5 24 29 110
5,000 3 18 21 78
500 1 29 30 82
50 0 16 16 62
0 (control) 0 14 14 72
Multiple (1 hr) 500 x 10 12 22 70 104 170
0 (control) 0 2 38 40 45
50 x 100 4 16 63 83 137
0 (control) 1 5 27 33 41
aICR strain used in single (1 hr) exposure studies; and A/J mice used in the multiple (1 hr) exposure studies.
Table 10. Overall summary: incidence of nonneoplastic changes and histologically proven neoplasms within the lungs of A/J
mice exposed to vinyl chloride in multiple inhalation exposures.
Incidence of response
Control (0 ppm), Vinyl chloride, 50 ppm,
100 x 1 100 x 1
Tissue/response M (39)a F (47)a M (81)a F (83)a
Lung (number evaluated) 39 45 77 81
Edema 2
Congestion 4 1 1
Focal hemorrhage 2 2
Pneumonitis 5 3 4 5
Bronchio-alveolar hyperplasia 3 3
Osseous metaplasia 1
Bronchio-alveolar adenoma 11 18 27 38
Bronchio-alveolar carcinoma 2 3 4
Reticulum cell sarcoma 1
13 18 30 43
aNumbers in parentheses denote animals per group. Total includes animals from scheduled sacrifice (8, 16, 20 month periods) and
spontaneous deaths.
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The fact that the severity of carcinogenic effects
ofVC had been described by various investigators
like Maltoni (2,5) and Lee et al. (6) to coincide with
dose and length of exposure implies that the total
dosage (concentration x exposure time) may be an
importantfactorinthecarcinogenicity ofVC. There-
fore, the inhaled dose was approximated by the
Haber (7) concept. In its simplest form this concept
states that the dosage, Ct is the product of C
(concentration in milligrams/cubic meters) and t
(time in minutes). The total concentration can also
be expressed in parts per million (ppm) and the
time can be expressed in hours, producing Ct in
ppm-hr. Factors for breathing rate and detoxica-
tion can be added. However, this simplified Ct
approximation of total inhaled dose is relatively
useful, as is, for comparative purposes.
In his experiments Maltoni (5, 10) exposed rats
and mice as shown in Table 12 to a series ofdoses of
VC ranging from 50 to 10,000 ppm for 4 hr/day, 5
days per week for 52 weeks. The results indicate a
questionable carcinogenic effect at 50 ppm or total
dosage of52,000 ppm-hr after 135 weeks. In anoth-
er experiment (BT3), Sprague-Dawley rats, treat-
ed in a similar fashion to BT1 but for 17 weeks only,
show after 86 weeks a negative carcinogenic re-
Table 11. Overall summary: incidence ofnonneoplastic changes and histologically proven neoplasms within the liver and lungs
of A/J mice exposed to vinyl chloride in multiple inhalation exposures.
Incidence ofresponse
Control (0 ppm), Vinyl chloride, 500 ppm,
10 x 1 10 x 1
Tissue/response M (46)a F (48)a M (78)a F (92)a
Liver (number evaluated) 45 48 78 89
Hepatic cell necrosis 4 6 6 13
Lymphoid cell infiltrate 1 1
Hepatic cell lipidosis 2 2
Neutrophil infiltrate 2 1
Bile duct hyperplasia 1
Granulomatous foci 1
Sinusoidal reticulosis 1
Hepatocyst 1
Amyloidosis 1
Angiectasis 1
Hepatic cell adenoma 1
Cholangiocarcinoma 1
11 6 13 16
Lung (number evaluated) 43 47 76 90
Edema 1
Pneumonitis 2
Bronchio-alveolar hyperplasia 2 1 2
Bronchio-alveolar adenoma 15 16 56 68
Bronchio-alveolar carcinoma 3 12 10
17 22 68 81
aNumbers in parentheses denote animals per group. Total includes animals from scheduled sacrifice (8, 16, 20 month periods) and
spontaneous deaths.
Table 12. Maltoni vinyl chloride studies.a
Test Species Results (carcinogenesis), ppm-hr
BT1 RATS Questionable at 52,000
BT3 RATS Negative at 17,000
Questionable at 85,000
Positive at 170,000; 850,000; 2,000,000; 3,000,000
BT6 RATS Positive at 24,600,000
BT7 RATS Negative at 52,000 and 260,000
Questionable at 520,000
Positive at 2,600,000; 6,200,000; 10,400,000
BT4 MICE Positive at 30,000; 150,000; 300,000; 600,000; 1,500,000; 3,600,000
Environmental Health Perspectives 70sponse at a total dose of 17,000 ppm-hr, a question-
able response at 85,000 ppm and a positive carcino-
genic response at 170,000 ppm-hr and above. In
experiment BT7, Wistar rats treated with VC at
doses ranging from 50 to 10,000 ppm, for4 hr daily,
5 days/week for 52 weeks in the same manner as
described above show positive carcinogenic affects
at total dosage of 2,600,000 ppm-hr. The author
suggests from comparison ofthe experimental data
obtained with two different strains ofrats (BT1/BT3),
Sprague-Dawley and (BT7) Wistar, that the strain
seems to be a factor in neoplastic response. Based
upon neoplastic lesions observed, the Wistar strain
was less responsive than Sprague-Dawley. Exper-
iment BT4 with Swiss mice, involving exposure to
VC at 50 to 10,000 ppm, 4 hr per day, 5 days per
week for 30 weeks produced carcinogenic effects
with atotal dosage Ctof30,000 to3,600,000 ppm-hr.
In the studies of Viola, Bigotti and Caputo (1),
tumors were seen in rats which had been exposed
to 30,000 ppm VC, 4 hr/day, 5 days/week, for 12
months. The total dose (Ct) of VC was 28,800,000
ppm-hr.
In the studies of Caputo, Viola and Bigotti (8),
rats and rabbits were exposed to VC for 4 hr/day, 5
days/week for 12 months at six dose levels. The
exposure to 50 ppm VC or total dose of 48,000
ppm-hr produced no tumors. Carcinogenic effects
were observed at total dosage of 320,000 ppm-hr
and above for rats and at 7,800,000 ppm-hr for
rabbits.
Keplinger et al. (9) exposed rats, hamsters and
mice to VC. Only the data on mice were sufficiently
complete for examination oftotal dose effect. Total
dosage of 56,000 ppm-hr and above produced tu-
mors in mice. The final report on the rats and
hamsters is still unavailable for evaluation.
Lee et al. (6) exposed mice and rats to three
levels of VC: 50, 250 and 1000 ppm, 5 hr/day, 5
days/weekfor up to 12 months. Alltestswith atotal
dose of 48,000 ppm-hr and below were essentially
negative formice. Positive carcinogenic effects were
noted, however, in mice above 78,000 ppm-hr.
The results of our study indicate that a positive
carcinogenic effect in rats may not appear until the
total dose (Ct) of VC exceeds 50,000 ppm-hr. The
single exposure study with ICR mice was negative
at 50 and 500 ppm-hr, borderline at 5000 ppm-hr
but did produce neoplastic lesions in the lung at
50,000 ppm-hr. The A/J mice exposed to multiple
doses ofVC, i.e., 50 ppm x 100 days x 1 hr or 500
ppm x 10days x 1 hrfor atotal cumulative dose of
VC of 5000 ppm-hr show a significant tumorigenic
response, but only at the higher dose level.
In our studies Fischer rats exposed to a total
dosage of50, 500, 5000, and 50,000 ppm VC for 1 hr
showed no chemically induc-ed tumor response. Nei-
ther did the Sprague-Dawley/Wistar rats that were
exposed to 500 ppm VC 1 hr/ day, 5 days/week for
10 weeks (total dosage 24,500 ppm-hr).
Table 13 summarizes various investigators' test
results, including our own, on vinyl chloride. The
tests with ICR mice, single exposure to VC, show
an increased frequency ofadenomas at total dosage
of 5000 ppm-hr and above. For A/J mice, repeated
exposures to 50 and 500 ppm VC for a total dosage
of 5000 ppm-hr shows a similar dose response pat-
tern for adenomas. In general, in terms of total
dosage Ct, carcinogenic effects are seen in the two
mice strains at Ct levels of 5000 to 50,000 ppm-hr.
Thus total dosage for carcinogenicity in mice is in
general agreement with Lee et al. (6) (78,000ppm-hr)
andMaltoni (5) (between30,000and 150,000ppm-hr)
and other investigators.
There is no doubt that risk is related to length of
exposure and hence total dose. In our discussion
much attention has been focused on the risk of
cancer associated with total dosage ofVC. Howev-
er, the multiple exposure experiment at 50 and 500
ppm dose levels with A/J mice for an equivalent
total exposure to 5000 ppm-hr appears inconsistent
with the thesis of total dosage. Indeed, it appears
Table 13. Other vinyl chloride studies.
Authors Species Results (carcinogenesis), ppm-hr
Viola, Bigotti and Caputo (1) Rats Positive 28,800,000
Caputo, Viola and Bigotti (8) Rats Negative at 48,000
Positive at 320,000; 1,280,000; 3,200,000; 6,400,000; 12,800,000
Rabbits Positive at 7,200,000
Keplinger et al. (9) Mice (rats and hamsters) Positive at 56,000
Lee (6) Mice All tests essentially negative below 78,000 and
positive above 78,000
Consumer Product Safety ICR mice 50 and 500, negative 5000, borderline positive
Commission (1979) A/J mice 50,000 positive
Fischer rats 50, 500, 5000 and 50,000, negative
24,500, eosinophilic loci, no cancers
October 1981 71from our own data that concentration may be the
dominant factor for acute or low level intermittent
exposures. This result may be explained on the
basis of a number of factors, i.e., metabolism, de-
toxication, DNA repair or a time for tumor devel-
opment for low level exposure beyond the animals'
lifespan.
As is evident from Table 13, the two strains of
rats, Fischer (344) and S-D/W, were more resistant
to the adverse effects of single and multiple inter-
mittent exposures of VC.
Our studies are in agreement as to the dose-time
relationship for carcinogenesis related to the VC
exposure. All of the continuous exposure studies
considered collectively indicate that there is a life-
time total dose (Ct) forVC. However, from ourown
studies with single or intermittent low level expo-
sures to VC we believe that concentration may be
the most dominant factor in whether or not carci-
nogenic effects are observed. For single dose stud-
ies with VC in ICR mice, neoplastic lesions were
produced at 5000 ppm. For multiple intermittent
exposures studies with A/J mice the critical concen-
tration for VC was 500 ppm, total dosage 5000
ppm-hr.
Approximate carcinogenic Ct levels ofVC based
on data for mice and rats are Ct = 5,000-50,000
ppm-hr, carcinogenic tendencies; 500,000 Ct > 50,000
ppm-hr, definite carcinogenicity; Ct > 500,000
ppm-hr, high incidence of carcinogenicity.
Considerations of Carcinogenicity
of VC: Conclusions
Cancer seems dependent on total dose of vinyl
chloride, especially in life-time exposure studies,
but for short-term exposure the concentration may
be the most critical factor.
One dose is sufficient ifdose is high enough. The
carcinogenic total dose was 5000 ppm-hr for mice
and 50,000 ppm-hr for rats.
There were apparent noncarcinogenic doses in
the study.
Mice were more sensitive indicators than rats for
carcinogenic effects of vinyl chloride.
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